The Central Drugs Standard Control Organisation (CDSCO) is contemplating waiving the testing requirement for cough syrups exported to select countries, including the US, UK, Canada, and several others.
This decision follows a request from industry stakeholders seeking exemptions from the mandatory testing implemented last year due to quality concerns over Indian cough syrups, which had been found contaminated with harmful substances. If approved, syrups manufactured in facilities recognized by the regulatory agencies of these countries may also be exempt from testing before export[1][2][3].
Citations:
[1] https://theprint.in/india/drugs-regulatory-body-may-waive-testing-requirement-for-cough-syrups-exported-to-certain-countries/2188033/
[2] https://www.news18.com/india/india-may-waive-testing-requirements-for-cough-syrups-exported-to-nine-countries-8974975.html
[3] https://www.ptinews.com/story/national/drugs-regulatory-body-may-waive-testing-requirement-for-cough-syrups-exported-to-certain-countries/1678445
[4] https://drugscontrol.org/news-detail.php?newsid=39907
[5] https://medicarepharmabusiness.com/dcgi-may-waive-testing-requirement-for-cough-syrups-exported-to-certain-countries/